These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
611 related articles for article (PubMed ID: 9792954)
1. Regulation of renal parathyroid hormone receptor expression by 1, 25-dihydroxyvitamin D3 and retinoic acid. Sneddon WB; Barry EL; Coutermarsh BA; Gesek FA; Liu F; Friedman PA Cell Physiol Biochem; 1998; 8(5):261-77. PubMed ID: 9792954 [TBL] [Abstract][Full Text] [Related]
2. Effects of vitamin D3 on keratinocyte proliferation and differentiation in vitro: modulation by ligands for retinoic acid and retinoid X receptors. Sørensen S; Sølvsten H; Politi Y; Kragballe K Skin Pharmacol; 1997; 10(3):144-52. PubMed ID: 9287395 [TBL] [Abstract][Full Text] [Related]
3. Retinoid X receptors stimulate and 9-cis retinoic acid inhibits 1,25-dihydroxyvitamin D3-activated expression of the rat osteocalcin gene. MacDonald PN; Dowd DR; Nakajima S; Galligan MA; Reeder MC; Haussler CA; Ozato K; Haussler MR Mol Cell Biol; 1993 Sep; 13(9):5907-17. PubMed ID: 8395017 [TBL] [Abstract][Full Text] [Related]
4. Prostate cancer cell type-specific involvement of the VDR and RXR in regulation of the human PTHrP gene via a negative VDRE. Sepulveda VA; Weigel NL; Falzon M Steroids; 2006 Feb; 71(2):102-15. PubMed ID: 16243370 [TBL] [Abstract][Full Text] [Related]
5. Parathyroid hormone down-regulates 1,25-dihydroxyvitamin D receptors (VDR) and VDR messenger ribonucleic acid in vitro and blocks homologous up-regulation of VDR in vivo. Reinhardt TA; Horst RL Endocrinology; 1990 Aug; 127(2):942-8. PubMed ID: 2164926 [TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of 1,25-dihydroxyvitamin D3 and 9-cis-retinoic acid on parathyroid hormone-related protein expression by oral cancer cells (HSC-3). Abe M; Akeno N; Ohida S; Horiuchi N J Endocrinol; 1998 Feb; 156(2):349-57. PubMed ID: 9518882 [TBL] [Abstract][Full Text] [Related]
7. Antiproliferative responses to two human colon cancer cell lines to vitamin D3 are differently modified by 9-cis-retinoic acid. Kane KF; Langman MJ; Williams GR Cancer Res; 1996 Feb; 56(3):623-32. PubMed ID: 8564982 [TBL] [Abstract][Full Text] [Related]
8. Expression of 25(OH)D3 24-hydroxylase in distal nephron: coordinate regulation by 1,25(OH)2D3 and cAMP or PTH. Yang W; Friedman PA; Kumar R; Omdahl JL; May BK; Siu-Caldera ML; Reddy GS; Christakos S Am J Physiol; 1999 Apr; 276(4):E793-805. PubMed ID: 10198318 [TBL] [Abstract][Full Text] [Related]
9. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice. Chow EC; Quach HP; Vieth R; Pang KS Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451 [TBL] [Abstract][Full Text] [Related]
10. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation. Raval-Pandya M; Freedman LP; Li H; Christakos S Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705 [TBL] [Abstract][Full Text] [Related]
11. The retinoid X receptor agonist 9-cis-retinoic acid and the 24-hydroxylase inhibitor ketoconazole increase activity of 1,25-dihydroxyvitamin D3 in human skin in vivo. Kang S; Li XY; Duell EA; Voorhees JJ J Invest Dermatol; 1997 Apr; 108(4):513-8. PubMed ID: 9077483 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of the PTH/PTHrP receptor by vitamin D3 in the osteoblast-like ROS 17/2.8 cells. Xie LY; Leung A; Segre GV; Yamamoto I; Abou-Samra AB Am J Physiol; 1996 Apr; 270(4 Pt 1):E654-60. PubMed ID: 8928773 [TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor activates a nuclear inhibitor of vitamin D and retinoid-X receptors. Fernandez-Martin JL; Kurian S; Farmer P; Nanes MS Mol Cell Endocrinol; 1998 Jun; 141(1-2):65-72. PubMed ID: 9723887 [TBL] [Abstract][Full Text] [Related]
14. The vitamin D hormone and its nuclear receptor: molecular actions and disease states. Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138 [TBL] [Abstract][Full Text] [Related]
15. Evidence for interference of vitamin D with PTH/PTHrP receptor expression in opossum kidney cells. Wald H; Dranitzki-Elhalel M; Backenroth R; Popovtzer MM Pflugers Arch; 1998 Jul; 436(2):289-94. PubMed ID: 9594030 [TBL] [Abstract][Full Text] [Related]
16. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone. Haussler MR; Jurutka PW; Hsieh JC; Thompson PD; Selznick SH; Haussler CA; Whitfield GK Bone; 1995 Aug; 17(2 Suppl):33S-38S. PubMed ID: 8579895 [TBL] [Abstract][Full Text] [Related]
17. Evidence for coordinated regulation of osteoblast function by 1,25-dihydroxyvitamin D3 and parathyroid hormone. van Leeuwen JP; Birkenhäger JC; van den Bemd GC; Pols HA Biochim Biophys Acta; 1996 Jun; 1312(1):54-62. PubMed ID: 8679716 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptors. Pathrose P; Barmina O; Chang CY; McDonnell DP; Shevde NK; Pike JW J Bone Miner Res; 2002 Dec; 17(12):2196-205. PubMed ID: 12469913 [TBL] [Abstract][Full Text] [Related]
19. The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands. Brown AJ; Zhong M; Finch J; Ritter C; Slatopolsky E Endocrinology; 1995 Apr; 136(4):1419-25. PubMed ID: 7895652 [TBL] [Abstract][Full Text] [Related]
20. Interaction between calcium and 1,25-dihydroxyvitamin D3 in the regulation of preproparathyroid hormone and vitamin D receptor messenger ribonucleic acid in avian parathyroids. Russell J; Bar A; Sherwood LM; Hurwitz S Endocrinology; 1993 Jun; 132(6):2639-44. PubMed ID: 8389284 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]